Disclaimer
The information contained on this web site is not an invitation or solicitation to invest in the shares of the company. It is produced for the purpose of description of the activities of the company, the research, the products and treatments. Any use of this information for the purpose of a financial transaction should be conducted through an independent financial advisor or professional consultant.
- Due diligence materials
- Advisory Board
- Key material agreements
- Clinical trial outsourcing
- Private Placement memorandum
- Corporate structure
- IP transfer agreement
- Share holder agreement
- Pathfinder strategy to eventually list the company on the London AIM market